Melissa Skala

Last updated
Melissa Caroline Skala
Alma mater Duke University (PhD)
University of Wisconsin-Madison (MS)
Washington State University
Scientific career
Institutions Vanderbilt University
Morgridge Institute for Research
Thesis Multiphoton microscopy, fluorescence lifetime imaging and optical spectroscopy for the diagnosis of neoplasia.  (2007)
Website Optical Microscopy in Medicine Lab

Melissa Caroline Skala is an American biomedical engineer who is a professor at the Morgridge Institute for Research. Her research considers photonics-based technologies for personalised medical therapies. She is a Fellow of The Optical Society, SPIE and American Institute for Medical and Biological Engineering.

Contents

Early life and education

As a child, Skala wanted to be an astronaut. She eventually studied physics at undergraduate at Washington State University, and during a summer research programme in biomedical optics decided to switch her attention to the emerging field of biomedical engineering. [1] [2] Skala graduated with a master's degree in biomedical engineering from the University of Wisconsin–Madison in 2004. [3] Skala was a graduate student at Duke University, where she developed fluorescence-lifetime imaging microscopy (FLIM) for the diagnosis of neoplasia. After graduating, Skala was made a postdoctoral research fellow at Duke University.[ citation needed ]

Research and career

In 2010 Skala was appointed an assistant professor at Vanderbilt University. [4] She spent six years at Vanderbilt before joining the University of Wisconsin–Madison in 2016. [5] Skala is Director of the Morgridge Institute for Research Optical Microscopy in Medicine Lab. Her research makes use of photonics-based technologies to monitor the function and interaction of immune cells. [1] [6] [7] In particular, Skala develops new treatments for cancer patients through the use of biopsies and autofluorescence. [1] She has shown that non-invasive, label-free fluorescence imaging can search through a patient's T cells, identify which might be the most useful for immunotherapy. [8] [9]

She has specialised in the treatment of pancreatic cancer, taking biopsies from tumours and creating organoids for laboratory-based investigations. These organoids are optically accessible, meaning Skala can evaluate the efficacy of different drugs and identify the optimised treatment regimes for specific patients. [10] Skala makes use of optical coherence tomography as an imaging tool during brain surgery and in the treatment of liver cancer. [10]

Alongside personalised treatment regimes, Skala has studied disparities in pancreatic cancer treatment, and whether ethnicity, location and insurance coverage impacts health outcomes. [11] She has shown that women, Black and Asian patients are less likely receive medical treatment than their white male counterparts. [11] Skala has developed organ-on-a-chip devices to study pulsatile flow and how it impacts cardiovascular disease. She is particularly interested in better understanding the irregularities in endothelial cells that occur in babies with heart defects. [12]

Awards and honours

Selected publications

Related Research Articles

Naomi J. Halas is the Stanley C. Moore Professor in Electrical and Computer Engineering, and Professor of biomedical engineering, chemistry and physics at Rice University. She is also the founding director of Rice University Laboratory for Nanophotonics, and the Smalley-Curl Institute. She invented the first nanoparticle with tunable plasmonic resonances, which are controlled by their shape and structure, and has won numerous awards for her pioneering work in the field of nanophotonics and plasmonics. She was also part of a team that developed the first dark pulse soliton in 1987 while working for IBM.

<span class="mw-page-title-main">Bruce J. Tromberg</span> American chemist

Bruce J. Tromberg is an American photochemist and a leading researcher in the field of biophotonics. He is the director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) within the National Institutes of Health (NIH). Before joining NIH, he was Professor of Biomedical Engineering at The Henry Samueli School of Engineering and of Surgery at the School of Medicine, University of California, Irvine. He was the principal investigator of the Laser Microbeam and Medical Program (LAMMP), and the Director of the Beckman Laser Institute and Medical Clinic at Irvine. He was a co-leader of the Onco-imaging and Biotechnology Program of the NCI Chao Family Comprehensive Cancer Center at Irvine.

<span class="mw-page-title-main">Indocyanine green</span> Chemical compound

Indocyanine green (ICG) is a cyanine dye used in medical diagnostics. It is used for determining cardiac output, hepatic function, liver and gastric blood flow, and for ophthalmic and cerebral angiography. It has a peak spectral absorption at about 800 nm. These infrared frequencies penetrate retinal layers, allowing ICG angiography to image deeper patterns of circulation than fluorescein angiography. ICG binds tightly to plasma proteins and becomes confined to the vascular system. ICG has a half-life of 150 to 180 seconds and is removed from circulation exclusively by the liver to bile.

Robert Alfano is an Italian-American experimental physicist. He is a Distinguished Professor of Science and Engineering at the City College and Graduate School of New York of the City University of New York, where he is also the founding Director of the Institute for Ultrafast Spectroscopy and Lasers (1982). He is a pioneer in the fields of Biomedical Imaging and Spectroscopy, Ultrafast lasers and optics, tunable lasers, semiconductor materials and devices, optical materials, biophysics, nonlinear optics and photonics; he has also worked extensively in nanotechnology and coherent backscattering. His discovery of the white-light supercontinuum laser is at the root of optical coherence tomography, which is breaking barriers in ophthalmology, cardiology, and oral cancer detection among other applications. He initiated the field known now as Optical Biopsy

Endomicroscopy is a technique for obtaining histology-like images from inside the human body in real-time, a process known as ‘optical biopsy’. It generally refers to fluorescence confocal microscopy, although multi-photon microscopy and optical coherence tomography have also been adapted for endoscopic use. Commercially available clinical and pre-clinical endomicroscopes can achieve a resolution on the order of a micrometre, have a field-of-view of several hundred µm, and are compatible with fluorophores which are excitable using 488 nm laser light. The main clinical applications are currently in imaging of the tumour margins of the brain and gastro-intestinal tract, particularly for the diagnosis and characterisation of Barrett’s Esophagus, pancreatic cysts and colorectal lesions. A number of pre-clinical and transnational applications have been developed for endomicroscopy as it enables researchers to perform live animal imaging. Major pre-clinical applications are in gastro-intestinal tract, toumour margin detection, uterine complications, ischaemia, live imaging of cartilage and tendon and organoid imaging.

The Beckman Laser Institute is an interdisciplinary research center for the development of optical technologies and their use in biology and medicine. Located on the campus of the University of California, Irvine in Irvine, California, an independent nonprofit corporation was created in 1982, under the leadership of Michael W. Berns, and the actual facility opened on June 4, 1986. It is one of a number of institutions focused on translational research, connecting research and medical applications. Researchers at the institute have developed laser techniques for the manipulation of structures within a living cell, and applied them medically in treatment of skin conditions, stroke, and cancer, among others.

<span class="mw-page-title-main">Stephen A. Boppart</span>

Stephen A. Boppart is a principal investigator at the Beckman Institute for Advanced Science and Technology at the University of Illinois at Urbana-Champaign, where he holds an Abel Bliss Professorship in engineering. He is a faculty member in the departments of electrical and computer engineering, bioengineering, and internal medicine. His research focus is biophotonics, where he has pioneered new optical imaging technologies in the fields of optical coherence tomography, multi-photon microscopy, and computational imaging.

Tayyaba Hasan is a Professor of Dermatology at the Wellman Center for Photomedicine at Harvard Medical School. She is one of the inventors of Visudyne, a Food and Drug Administration approved treatment for age-related macular degeneration. She received the 2018 SPIE Britton Chance Biomedical Optics Award.

Elizabeth M. C. Hillman is a British-born academic who is Professor of Biomedical Engineering and Radiology at Columbia University. She was awarded the 2011 Adolph Lomb Medal from The Optical Society and the 2018 SPIE Biophotonics Technology Innovator Award.

<span class="mw-page-title-main">Laura Waller</span> Computer scientist

Laura Ann Waller is a computer scientist and Ted Van Duzer Endowed Associate Professor at the University of California, Berkeley. She was awarded a Chan Zuckerberg Initiative Fellowship to develop microscopes to image deep structures within the brain in 2017 and won the 2018 SPIE Early Career Award.

<span class="mw-page-title-main">Andrea Armani</span> American chemical engineer

Andrea Martin Armani is the Ray Irani Chair in Engineering and Materials Science and Professor of Chemical Engineering and Materials Science at the USC Viterbi School of Engineering. She was awarded the 2010 Presidential Early Career Award for Scientists and Engineers from Barack Obama and is a World Economic Forum Young Global Leader.

<span class="mw-page-title-main">Anita Mahadevan-Jansen</span> Biomedical engineer

Anita Mahadevan-Jansen is a Professor of Biomedical Engineering and holds the Orrin H. Ingram Chair in Biomedical Engineering at Vanderbilt University. Her research considers the development of optical techniques for clinical diagnosis and surgical guidance, particularly using Raman and fluorescence spectroscopy. She serves on the Board of Directors of SPIE, and is a Fellow of SPIE, The Optical Society, Society for Applied Spectroscopy, and the American Society for Lasers in Medicine and Surgery. She has been elected to serve as the 2020 Vice President of SPIE. With her election, Mahadevan-Jansen joins the SPIE presidential chain and will serve as President-Elect in 2021 and Society's President in 2022.

Kristen Carlson Maitland is an associate professor at Texas A&M University. She develops optical instrumentation for the detection and diagnosis of diseases, including infection and cancer. She has served on the Board of Directors of SPIE.

D. Lansing Taylor is the Director at the University of Pittsburgh Drug Discovery Institute (UPDDI), Pennsylvania and a faculty member in the Department of Computational and Systems Biology.

Laura Marcu is an American scientist and a professor of biomedical engineering and neurological surgery at the University of California, Davis. She is also a Fellow of numerous professional societies: the Biomedical Engineering Society, SPIE, The Optical Society and the National Academy of Inventors.

Nimmi Ramanujam is the Robert W. Carr Professor of Biomedical Engineering, and a faculty member in the Global Health Institute and the Department of Pharmacology & Cell Biology at Duke University. She is the director of the Center of Global Women's Health Technologies (GWHT) and founder of Zenalux Biomedical Inc. and Calla Health. Ramanujam has spent the last two decades developing precision diagnostics and more recently precision therapeutics for breast and cervical cancer, with a focus on addressing global health disparities. She has more than 20 patents and over 150 publications for screening, diagnostic, and surgical applications, and has raised over $30M of funding to pursue these innovations through a variety of funding mechanisms, including NIH R01s and R21s, NIH Bioengineering Partnerships, NCI Academic Industry Partnerships, NIH Small Business grants and USAID funding. As the founding director of the Center for Global Women's Health Technologies at Duke University, she has developed a consortium of over 50+ partners including international academic institutions and hospitals, non-governmental organizations, ministries of health, and commercial partners; this consortium is working to ensure that the technologies developed at the center are adopted by cancer control programs in geographically and economically diverse healthcare settings.

<span class="mw-page-title-main">Christine P. Hendon</span> American electrical engineer and computer scientist

Christine P. Hendon is an electrical engineer and computer scientist and an associate professor in the Department of Electrical Engineering at Columbia University in New York City. Hendon is a pioneer in medical imaging. She develops biomedical optics technologies, using optical coherence tomography and near infrared spectroscopy systems, that enable physicians to perform guided interventional procedures and allow for structure-function dissection of human tissues and organs. Her advances in imaging technologies have led to improved diagnostic abilities and treatments for cardiac arrhythmias as well as breast cancer and preterm birth. She has been recognized for her development of optical imaging catheters for cardiac wall imaging by Forbes 30 under 30, the MIT Technology Review’s 35 Innovators Under 35, and by President Obama with the Presidential Early Career Awards in 2017.

Audrey K. Ellerbee Bowden is an American engineer and Dorothy J. Wingfield Phillips Chancellor's Faculty Fellow at Vanderbilt University, as well as an Associate Professor of Biomedical Engineering and Electrical Engineering. She is a Fellow of Optica, the American Institute for Medical and Biological Engineering and the International Society for Optics and Photonics (SPIE).

Irene Georgakoudi is a Greek biophysicist and Professor of Biomedical Engineering at Tufts University, where her work focuses on developing non-invasive medical imaging techniques based on optical spectroscopy for applications in medical diagnostics and therapeutics.

Jennifer Kehlet Barton is an American biomedical engineer who is Director of the BIO5 Institute at the University of Arizona. Barton develops optical techniques for the detection and treatment of cancer.

References

  1. 1 2 3 4 "Fellow Profiles/ Melissa Skala".{{cite web}}: CS1 maint: url-status (link)
  2. "Skala Lab". Morgridge Institute for Research. Retrieved 2020-11-19.
  3. "UW Week in Review: August 17–21". Wisconsin Alumni Association. 2020-08-21. Retrieved 2020-11-17.
  4. "Melissa Skala | VUMC Reporter | Vanderbilt University". news.vumc.org. Retrieved 2020-11-19.
  5. "Tom Still: People win when collaboration leverages Wisconsin research assets". madison.com. Retrieved 2020-11-19.
  6. "Skala, PhD, Melissa". McPherson Eye Research Institute. 14 August 2017. Retrieved 2020-11-17.
  7. "Next Generation: Observing Cancer-Associated Mitochondrial Changes". The Scientist Magazine®. Retrieved 2020-11-19.
  8. Mattmiller, Brian (2018-10-23). "Turning T cells into better cancer assassins". Morgridge Institute for Research. Retrieved 2020-11-19.
  9. "Innovator profile: Melissa Skala". Discovery to Product. 28 August 2020. Retrieved 2020-11-19.{{cite web}}: CS1 maint: url-status (link)
  10. 1 2 "Melissa Skala plenary presentation: Imaging Cellular Heterogeneity in". spie.org. Retrieved 2020-11-17.
  11. 1 2 Mohns, Mariel (2020-11-17). "Breaking down barriers to pancreatic cancer care in Wisconsin". Morgridge Institute for Research. Retrieved 2020-11-19.
  12. Mohns, Mariel (2020-11-16). "Measuring blood flow with a beating "heart-on-a-chip"". Morgridge Institute for Research. Retrieved 2020-11-19.
  13. Mattmiller, Brian (2016-02-05). "Melissa Skala: Follow the Light to Better Cancer Treatment". Morgridge Institute for Research. Retrieved 2020-11-19.
  14. "The Ride to Announce Ride Scholar Class of 2019". The Ride. 2019-12-13. Retrieved 2020-11-17.
  15. "Melissa Skala - Wisconsin Alumni Research Foundation". WARF. 2020-02-01. Retrieved 2020-11-17.
  16. "Melissa Skala". spie.org. Retrieved 2020-11-17.
  17. 1 2 "Twice as nice: Skala earns pair of fellow honors". College of Engineering - University of Wisconsin-Madison. 2019-03-25. Retrieved 2020-11-17.